Clinical TrialsSearch results
Number of results: 52688
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- A PHASE 3, MULTICENTER, MULTINATIONAL,
OPEN-LABEL EXTENSION STUDY TO EVALUATE
THE LONG-TERM SAFETY OF CC-93538 IN ADULT
AND ADOLESCENT SUBJECTS WITH EOSINOPHILIC
ESOPHAGITIS
- eosinophilic esophagitis
- Zhang Changliang
- 2022-01-22
Not yet recruiting
- A prospective study on the efficacy and safety of double stenting with a narrow covered self-expandable metallic stent (SEMS) for malignant distal bile duct stenosis
- obstructive jaundice
- Shiomi Hideyuki
- 2022-01-22
Not yet recruiting
- A retrospective, 12-month, multicenter study to evaluate real-world brolucizumab effectiveness and safety in Japanese patients with neovascular age-related macular degeneration (nAMD)
- neovascular Age-related Macular Degeneration
- Takuma Okada
- 2022-01-22
Not yet recruiting
- Analgesic management in pediatric patients undergoing laparoscopic inguinal hernia surgery
- Inguinal hernia
- Suzuki Takeshi
- 2022-01-22
Recruiting
- Clinical Trial of Limb Wearable Cyborg HAL to Verify the Functional Effect for Motor Postural Disorders in the Stages of Child Development with Cerebral Palsy
- Patients with motor postural disorder associated with pediatric cerebral palsy, etc.
- Marushima Aiki
- 2022-01-22
Recruiting
- Investigation of optimal first-line technique of endovascular therapy for acute ischemic stroke
- Acute ischemic stroke
- Toyoda Kazunori
- 2022-01-22
Recruiting
- Observational Study of RAS monitoring for RAS/BRAF wild advanced Colorectal Cancer Patients treated with anti EGFR antibody
- colorectal cancer
- Kataoka Kozo
- 2022-01-22
Recruiting
- Phase II trial of Survivin-responsive oncolytic adenovirus (Surv.m-CRA-1) by repeated intratumoral injection in advanced bone tumor patients.
- Advanced primary malignant bone tumor
- Nagano Satoshi
- 2022-01-22
Not yet recruiting
- A clinical study on gait in Parkinson's disease using a dual task
- Parkinson's disease
- Seki Morinobu
- 2022-01-21
Not yet recruiting
- A randomized, participant and investigator-blinded, placebo-controlled, single ascending intravenous and single subcutaneous dose study to assess the safety, tolerability and pharmacokinetics of CMK389 in Japanese healthy participants
- Japanese healthy participants
- Yamada Hiroyuki
- 2022-01-21